These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 32047260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
    Yang J, Hu S, Wang C, Song J, Chen C, Fan Y, Ben-David Y, Pan W.
    Eur J Med Chem; 2020 Jan 15; 186():111898. PubMed ID: 31784186
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
    Zheng YT, Yang HY, Li T, Zhao B, Shao TF, Xiang XQ, Cai WM.
    Acta Pharmacol Sin; 2015 May 15; 36(5):614-26. PubMed ID: 25864651
    [Abstract] [Full Text] [Related]

  • 6. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F, Li H, Yan XG, Zhou ZW, Yi ZG, He ZX, Pan ST, Yang YX, Wang ZZ, Zhang X, Yang T, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 May 15; 9():575-601. PubMed ID: 25632225
    [Abstract] [Full Text] [Related]

  • 7. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway.
    Wang W, Xiong H, Li L, Hu X, Zhuang W, Li J, Sun X, Yu Y, Yu Y, Guo Y, Wang Y, Wang R, Wang H, Li Q.
    Bioorg Chem; 2024 Jul 15; 148():107436. PubMed ID: 38735265
    [Abstract] [Full Text] [Related]

  • 8. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT, Chen H, Ni ZL, Liu HB, Tong HF, Fan L, Liu A, Qiu MX, Liu DL, Guo HC, Wang ZH, Lin SZ.
    Int J Oncol; 2011 Dec 15; 39(6):1381-90. PubMed ID: 21805032
    [Abstract] [Full Text] [Related]

  • 9. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
    Qazi AK, Hussain A, Khan S, Aga MA, Behl A, Ali S, Singh SK, Taneja SC, Shah BA, Saxena AK, Mondhe DM, Hamid A.
    Cancer Lett; 2015 Apr 01; 359(1):47-56. PubMed ID: 25554016
    [Abstract] [Full Text] [Related]

  • 10. 8-Chrysoeriol, as a potential BCL-2 inhibitor triggers apoptosis of SW1990 pancreatic cancer cells.
    Zhang Y, Li Z, Min Q, Palida A, Zhang Y, Tang R, Chen L, Li H.
    Bioorg Chem; 2018 Apr 01; 77():478-484. PubMed ID: 29454280
    [Abstract] [Full Text] [Related]

  • 11. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P, Arienti C, Amadori D, Fabbri F, Carloni S, Tesei A, Vannini I, Silvestrini R, Zoli W.
    J Cell Physiol; 2009 Jul 01; 220(1):214-21. PubMed ID: 19288493
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X.
    Drug Des Devel Ther; 2017 Jul 01; 11():1115-1126. PubMed ID: 28435223
    [Abstract] [Full Text] [Related]

  • 13. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
    Chen J, Wang T, Xu S, Zhang P, Lin A, Wu L, Yao H, Xie W, Zhu Z, Xu J.
    Eur J Med Chem; 2017 Jul 28; 135():414-423. PubMed ID: 28463784
    [Abstract] [Full Text] [Related]

  • 14. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
    Kamal A, Lakshma Nayak V, Nagesh N, Vishnuvardhan MV, Subba Reddy NV.
    Bioorg Chem; 2016 Jun 28; 66():124-31. PubMed ID: 27149364
    [Abstract] [Full Text] [Related]

  • 15. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
    Tan J, You Y, Xu T, Yu P, Wu D, Deng H, Zhang Y, Bie P.
    Toxicol Lett; 2014 Jan 03; 224(1):7-15. PubMed ID: 24144893
    [Abstract] [Full Text] [Related]

  • 16. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J, Yuan Z, Sun Y, Bu Y, Li W, Fei Z.
    Biomed Pharmacother; 2017 Dec 03; 96():619-625. PubMed ID: 29035827
    [Abstract] [Full Text] [Related]

  • 17. Cucurmosin induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway.
    Zhang B, Huang H, Xie J, Xu C, Chen M, Wang C, Yang A, Yin Q.
    Oncol Rep; 2012 Mar 03; 27(3):891-7. PubMed ID: 22139427
    [Abstract] [Full Text] [Related]

  • 18. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X, Wang D, Yang T, Pan SY, Chen XW, Zhou SF.
    Drug Des Devel Ther; 2015 Mar 03; 9():1293-318. PubMed ID: 25767376
    [Abstract] [Full Text] [Related]

  • 19. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
    Xie M, Yi X, Wang R, Wang L, He G, Zhu M, Qi C, Liu Y, Ye Y, Tan S, Tang A.
    Cell Physiol Biochem; 2014 Mar 03; 33(5):1475-83. PubMed ID: 24854624
    [Abstract] [Full Text] [Related]

  • 20. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK, Graab U, Fulda S.
    Cancer Lett; 2013 Sep 01; 337(2):200-9. PubMed ID: 23684925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.